News | December 10, 2007

Technique May Allow Doctors To Tailor Treatment For Cervical Cancer

December 11, 2007 - A recent study found that with cervical cancer, treatments such as chemotherapy can nearly double a woman’s chance of survival if there is good blood flow inside of the tumor.

By the end of 2007, more than 11,000 women will have been told they have cervical cancer, but doctors are getting better at treating it and increasing patients' chances of survival. They're making those improvements with the help of some high-tech imaging.

Linda Witter knows just how quickly cancer can change your life. After the thrill of winning an Olympic medal as the coach of the U.S. Synchronized Swim Team, she found herself in the battle of her life with cervical cancer.

"When the medalists and everybody was getting ready to visit the President, I was told I had cancer. And it really was the worst day of my life," said Witter.

That was nearly four years ago. Today, Witter is a cervical cancer survivor. Because of new research led by Nina Mayr, M.D., at Ohio State University's James Cancer Hospital, there may be even more women like Witter. Dr. Mayr and her team have found that by using MRI technology, they can monitor treatments in women as they are given.

"The innovative thing about the MRI is that we are doing it during treatment - not before and after. That's because we need to measure what the blood flow is like during treatment," said Dr. Mayr.

In a recent study, Dr. Mayr and her colleagues found that if a woman has enough red blood cells, and there is good blood flow inside the tumor, treatments like chemotherapy can nearly double a woman's chances of survival. If the MRI shows both red blood cells and blood flow are low, doctors can then alter their treatment to be more aggressive.

"I think we're very excited that we found yet another piece to the puzzle that can help us make the treatment more individualized for the patient and hopefully get them a better chance," said Dr. Mayr.

Dr. Mayr's study shows that if a woman's red blood cells and blood flow inside the tumor are good, the chance of survival jumps from 56 percent to over 90 percent. Doctors say it's important for women to get an annual pap smear test to check for cervical cancer because there are often no signs or symptoms until it's in the later stages.

For more information:

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init